Malignant Meningeal Neoplasm — Trials

Malignant Meningeal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

107 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 41
Recruiting: 19
Ph III recruiting: 0
Growth YoY: —
Industry share: 7%
Top sponsor: Guangzhou Medical University
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (13)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04315246	177Lu-DTPA-Omburtamab Radioimmunotherapy for Leptomeningeal Metastasis From Solid Tumors (Breast, NSCLC, Malignant Melanoma)	withdrawn	Phase 1 / Phase 2	0	Y-mAbs TherapeuticsINDUSTRY	2	Jul 15, 2022	clinicaltrials
NCT02194452	Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors	withdrawn	N/A	0	Sue O'DorisioOTHER	1	Apr 28, 2017	clinicaltrials